New Clinical Trial Testing On-Demand Use of Deucrictibant in Patients With Hereditary Angioedema by Madaline Spencer| Published on: Mar 20, 2026

New Clinical Trial Testing On-Demand Use of Deucrictibant in Patients With Hereditary Angioedema by Madaline Spencer| Published on: Mar 20, 2026 Peng Lu, MD, PhD, Chief Medical Officer at Pharvaris, and Wim Souverijns, PhD, Chief Commercial Officer at Pharvaris, discuss the RAPIDe-3 clinical trial of deucrictibant for patients with hereditary angioedema (HAE). https://checkrare.com/new-clinical-trial-testing-on-demand-use-of-deucrictibant-in-patients-with-hereditary-angioedema/